Huntington's Disease And Its Effects On Vision And Eye Health
Published on: October 29, 2024
huntington's disease and its effects on vision and eye health featured image
Article reviewer photo

Alejandra Briones

Bsc in Biomedical Sciences, University of Bristol

Introduction

Huntington's disease (HD) is an autosomal genetic neurodegenerative disorder, predominantly affecting individuals aged 30 to 50.1 HD causes motor dysfunctions such as muscle rigidity, cognitive decline, and psychiatric symptoms such as depression and irritability, which tend to be progressive in nature.2 HD also contributes to problems in vision and eye health, where patients may experience slow and abnormal eye movements, leading to difficulties with gaze and coordination. This article provides an overview of visual disturbances in HD and their impact on daily living and psychosocial well-being. Since these disturbances often appear as early signs of the disease, understanding them is crucial for early intervention.

Pathophysiology of Huntington’s Disease

HD is a neurodegenerative disease caused by a mutation in the HTT gene (encoding the huntingtin protein), leading to the abnormal expansion of CAG trinucleotide (Cytosine, Adenine, and Guanine) repeats. While in normal people, the CAG repeats range typically between 10 and 35, it exceeds with sometimes over 50 repeats in people with HD. The more CAG repeats present, the earlier the onset and severe progression of the disease. As an autosomal disease, the chance of a child inheriting the mutated gene from an affected parent is about 50%.3

The repeats of CAG cause a breakdown of nerve cells, primarily in the basal ganglia and striatum, regions in the brain that control movement and cognition. Patients experience motor symptoms such as chorea (involuntary and jerky muscle movements), bradykinesia (slowed movement), dystonia (abnormal muscle contractions), impaired higher-level cognition (reasoning and decision-making), and psychiatric symptoms (irritability, anxiety, depression, apathy, and suicidal tendencies).

The neurodegenerative process of HD may be traced back to several pathological mechanisms such as oxidative stress, mitochondrial dysfunction, disrupted cellular signalling, and impaired protein degradation. Excessive glutamate signalling causes excitotoxicity, causing overstimulation and neuronal death. These mechanisms contribute to the toxic effects of the mutating huntingtin protein, as well as the eventual progression of symptoms.

Vision and eye health in HD

Research has begun to explore how Huntington’s disease also affects vision and eye health. The resulting pathophysiology further causes degeneration in neurons in regions responsible for visual processing and motor control. Therefore, individuals with HD may experience difficulties in visual acuity, depth perception, and controlling eye movements, related to changing fixed targets. Understanding structural and functional networks pertinent to vision and motor control provides insights into disease management for individuals with HD.

Oculomotor Abnormalities

One of the ways that HD affects the visual system is through saccades. Saccades are rapid and simultaneous movements of both eyes, responsible for shifting the line of sight from one point to another. Saccades are especially essential to reading, scanning a scene, and redirecting focus quickly. In Huntington’s disease, saccades are often disrupted, indicating a neurological deterioration of the disease.

Specifically, individuals with HD have difficulty in repressing reflexive saccades. As explained in the name, reflexive saccades represent automatic eye movements triggered by sudden visual stimuli.4 In healthy individuals, the brain can normally inhibit reflexive saccades when needed and allow for focused attention to a task or object. In HD, however, compromised networks and regions result in the inhibitory control being compromised. Similarly, patients also face difficulty in initiating voluntary saccades – deliberate eye movements to consciously focus on a moving target. As initiation of saccades involves precise coordination between regions such as the eyes and basal ganglia, impaired networks result in delayed saccade initiation.5

Early onset HD results in a gradual slowing of saccades, where the disease begins to severely impact motor control centres. While the exact extent of this pathology is unknown, research highlights the role of frontal cortical regions responsible for higher-level association.

Vision Perception Issues

One of the critical areas of cognitive decline surrounding vision in HD is visual object and visuo-spatial perception and processing. Two studies conducted revealed a significant impairment in patients’ spatial recognition and pattern memory, as well as those with early stages of HD exhibiting longer response times (cognitive slowing).

A study that aimed to test various facets of perception in patients with HD revealed interesting results. The Delayed Matching-to-Sample task, assessing simultaneous and delayed matching, revealed significant impairments in patients with HD, suggesting the disruption of perception and attention along with memory retention. Impairments were also exhibited in visual search tasks, along with increasing complexity. Patients with HD primarily differentiated from healthy cohorts by showing slower reaction times, contributing to inefficient cognitive processing.

In the Paired Associates Learning and Working Memory task, patients with HD performed less than controls, reflecting associative memory and learning disruptions. Spatial working memory was also impaired.6

Another study focused on visual perception disturbances in HD, particularly the magnocellular (M) pathway responsible for motion detection. Among 289 participants, including HD gene carriers, the study found that HD patients and those close to disease onset exhibited impaired contrast sensitivity for moving stimuli. This suggests early and selective magnocellular pathway involvement, while the parvocellular (P) pathway, associated with high spatial frequency and colour, was less affected. The M pathway, responsible for gross visual data processing, has a high temporal resolution, allowing it to process fast-changing visual stimuli. This is essential for detecting rapid movements and changes in the visual environment. Therefore, with impairments over time, the reduced sensitivity leads to difficulties in discerning objects from the background.7

The cognitive impairments observed in HD, particularly in visual object and visuospatial processing, point to a broader deficit in attentional and decision-making processes, linked to corticostriatal circuits. The deficits in HD appear to involve difficulties in stimulus selection, discrimination, and response execution, rather than retention over time. Early detection of visual perceptual changes may allow for earlier interventions, potentially slowing disease progression.           

Impact of daily life and quaLity of life 

Eventual progression or advancement of the disease results in various psychosocial issues – such as emotional disturbances and cognitive decline. Further triggered by motor dysfunction and problems with vision, Huntington’s disease poses a serious inconvenience and barrier to overcome and affects mental health and overall quality of life.8

As visual acuity, eye movement control, and depth perception decline, patients may face increased levels of anxiety and fear in navigating their environment and performing basic tasks. Compounded by the lack of confidence in their ability to complete their tasks leads to uncertainty about their future abilities and independence. Moreover, patients are also at a risk for depression – where they face a profound sense of loss of their autonomy. With increasing frustration and helplessness, patients are faced with significant emotional burdens, which contribute to the worsening of mental health. One of the largest comorbidities associated with Huntington’s disease is suicide.9

Lastly, one of the most common yet debilitating symptoms that patients with HD face is social isolation, a common outcome of vision problems. Reduced ability and confidence to interact effectively with others and participate in social activities leads to withdrawal, thereby diminishing their quality of life and thus, begins the cycle of disengagement, stress, and depression.10

Another facet of the impact of vision problems in HD is the levels of daily functioning. As tasks like reading, cooking, and personal care become increasingly challenging, patients tend to rely more on caregivers, eroding their self-esteem and increasing caregiver stresses and burdens.

Management & Treatment  

To mitigate the negative impacts of vision problems in HD, it is essential to integrate vision care into comprehensive disease management. Regular eye examinations can help identify and address visual impairments early. Visual aids, such as magnifiers and adaptive technologies, can assist in managing daily tasks and maintaining independence. Occupational therapy can provide strategies for adapting the living environment to better support patients with vision loss.

Furthermore, psychological support tailored to the unique challenges of vision loss in HD can be beneficial. Counselling and support groups can offer emotional support and coping strategies, helping patients manage the psychological impacts of vision impairment. Support for caregivers is equally important, as they play a crucial role in assisting patients and managing the associated challenges.

In conclusion, vision problems in Huntington’s disease have far-reaching effects on both mental health and quality of life. The interplay between deteriorating vision, heightened anxiety, depression, and social isolation underscores the need for comprehensive care strategies. Addressing vision impairments through medical interventions, adaptive technologies, and psychological support can significantly improve the well-being of individuals with HD. By acknowledging and addressing these challenges, healthcare providers can enhance patients' and their families' overall quality of life, offering a more holistic approach to managing Huntington’s disease.

Summary 

  • Huntington’s Disease is a neurodegenerative disorder which primarily affects motor, cognitive, and psychiatric functions. 
  • Specifically in vision-based disturbances, individuals with HD often experience disrupted eye movements, difficulties with visual perception, and impaired depth perception. These visual disturbances contribute to reduced quality of life, increased anxiety, depression, and social isolation. 
  • Vision-related challenges affect daily functioning and reliance on caregivers. Early detection and management, including regular eye exams, visual aids, and psychological support, are essential to maintaining independence and improving well-being for HD patients. 
  • Therefore, comprehensive care comprising clinical, occupational, and psychological therapy is crucial for enhancing physical and emotional health in individuals with HD.

References

  1. Roos RA. Huntington’s disease: a clinical review. Orphanet Journal of Rare Diseases [Internet]. 2010 Dec 20;5(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022767/
  2. Ajitkumar A, De Jesus O. Huntington Disease [Internet]. PubMed. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559166/#:~:text=Huntington%20disease%20is%20an%20autosomal
  3. Huang WJ, Chen WW, Zhang X. Huntington’s disease: Molecular basis of pathology and status of current therapeutic approaches. Experimental and Therapeutic Medicine [Internet]. 2016 Aug 4;12(4):1951–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038571/
  4. Yadav R, Patel K, Kamble N, VikramV Holla, Pal P. Evolution of eye movement abnormalities in Huntington’s disease. Annals of Movement Disorders. 2022 Jan 1;5(1):1–1.
  5. Lasker AG, Zee DS. Ocular motor abnormalities in Huntington’s disease. Vision Research. 1997 Dec;37(24):3639–45.
  6. Lawrence AD. Visual object and visuospatial cognition in Huntington’s disease: implications for information processing in corticostriatal circuits. Brain. 2000 Jul 1;123(7):1349–64.
  7. O’DONNELL BF, BLEKHER TM, WEAVER M, WHITE KM, MARSHALL J, BERISTAIN X, et al. Visual perception in prediagnostic and early stage Huntington’s disease. Journal of the International Neuropsychological Society. 2008 Apr 17;14(03):446–53.
  8. Bilal H, Harding IH, Stout JC. The relationship between disease-specific psychosocial stressors and depressive symptoms in Huntington’s disease. Journal of Neurology [Internet]. 2023 Sep 11; Available from: https://pubmed.ncbi.nlm.nih.gov/37695532/
  9. Finkbeiner S. Huntington’s Disease. Cold Spring Harbor Perspectives in Biology [Internet]. 2011 Mar 16;3(6):a007476–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098678/
  10. Gunn S, Dale M, Noora Ovaska-Stafford, Maltby J. Mental health symptoms among those affected by Huntington’s disease: A cross‐sectional study. Brain and behavior. 2023 Mar 6;13(4).
Share

Purnima Bhanumathi Ramakrishnan

MSc Cognitive Neuroscience and Human Neuroimaging, The University of Sheffield

arrow-right